LONDON--(BUSINESS WIRE)--Gyroscope Therapeutics Holdings plc (Gyroscope), a clinical-stage gene therapy company focused on diseases of the eye, today announced that Sanofi, a global biopharmaceutical ...
Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, announced the initiation of its phase II programme evaluating its investigational gene therapy, GT005, for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results